Amid lab space scarcity, a life sciences complex to rise in South San Francisco hub

Amber Tong

The ever-expanding group of biotechs moving into Oyster Point can now expect new neighbors as the booming life sciences hub in South San Francisco continues …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Amid lab space scarcity, a life sciences complex to rise in South San Francisco hub

Amber Tong

Sign up to read this article for free.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Roivant brings rare disease program closer as Immunovant CEO retires

FDA approves Dupixent for hives, rejects new Eylea dosing schedule

Exclusive: VelaVigo inks another US biotech deal as China drug development scene booms

Sanofi to pay $125M upfront for two immunology drugs from little-known biotech

UnitedHealth reports 'unusual and unacceptable' earnings as Medicare costs climb

ADSTILADRIN® (nadofaragene firadenovec-vncg) – A Growing Body of Clinical Data and Real-World Evidence

Amid lab space scarci­ty, a life sci­ences com­plex to rise in South San Fran­cis­co hub

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Amid lab space scarcity, a life sciences complex to rise in South San Francisco hub